|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.49 CNY | +0.81% |
|
-6.44% | -14.45% |
Shandong Sinobioway Biomedicine Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 83.8 million compared to CNY 75.6 million a year ago. Net loss was CNY 27.7 million compared to CNY 21.51 million a year ago.
Basic loss per share from continuing operations was CNY 0.042 compared to CNY 0.0326 a year ago. Diluted loss per share from continuing operations was CNY 0.042 compared to CNY 0.0326 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.45% | 1.14B | |
| -2.32% | 90.45B | |
| +3.68% | 41.45B | |
| -10.90% | 33.57B | |
| +58.05% | 25.73B | |
| -19.56% | 14.73B | |
| -9.06% | 12.82B | |
| -11.34% | 11.7B | |
| -43.53% | 11.44B | |
| +3.75% | 8.79B |
SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD. 